The Cosentyx Drug Market is driven by growing prevalence of psoriasis and psoriatic arthritis The Cosentyx drug market is mainly driven by the growing prevalence of psoriasis and psoriatic arthritis globally. Cosentyx is a human monoclonal antibody used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by selectively binding to interleukin-17A (IL-17A), preventing it from inducing inflammation. Cosentyx provides long-lasting relief...
0 hisse senetleri
33 Views
0 önizleme